Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Mar. 15, 2022 | Jun. 30, 2021 | |
Cover [Abstract] | |||
Document Type | 10-K/A | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Annual Report | true | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-35890 | ||
Entity Registrant Name | Tempest Therapeutics, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 45-1472564 | ||
Entity Address, Address Line One | 7000 Shoreline Court, | ||
Entity Address, Address Line Two | Suite 275 | ||
Entity Address, City or Town | South San Francisco, | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 94080 | ||
City Area Code | (415) | ||
Local Phone Number | 798-8589 | ||
Title of 12(b) Security | Common Stock, $0.001 par value | ||
Trading Symbol | TPST | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 74.2 | ||
Entity Common Stock, Shares Outstanding | 7,173,094 | ||
Documents Incorporated by Reference | Portions of the registrant’s definitive Proxy Statement for its 2022 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by the Annual Report on Form 10-K 10-K. | ||
Security Exchange Name | NASDAQ | ||
Entity Central Index Key | 0001544227 | ||
Amendment Flag | true | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Amendment Description | Tempest Therapeutics, Inc. (the “Company,” “our,” “us” or “we”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment No. 1”) to our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Form 10-K”), which was filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2022, to file Exhibits 4.1 and 21.1 to the Form 10-K, which were unintentionally omitted from the Form 10-K. As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by the registrant’s principal executive officer and principal financial officer are filed as exhibits to this Amendment No. 1. Item 15 of Part IV is also being amended to reflect the filing of these new certifications, the filing of Exhibits 4.1 and 21.1, the sequential renumbering of certain exhibits, the removal of inapplicable legends and the addition of Exhibit 104. No other changes have been made to the Form 10-K other than those described above. This Amendment No. 1 does not reflect subsequent events occurring after the original filing date of the Form 10-K or modify or update in any way the financial statements, consents or any other items or disclosures made in the Form 10-K in any way other than as required to reflect the amendments discussed above. Accordingly, this Amendment No. 1 should be read in conjunction with the Form 10-K. |
Audit Information
Audit Information | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Auditor [Abstract] | ||
Auditor Name | Ernst & Young LLP | Deloitte & Touche LLP |
Auditor Location | Grand Rapids, Michigan | San Francisco, California |
Auditor Firm ID | 42 | 34 |